Single-Arm Study of a Treatment for Dry Eye in People Who Struggle to Wear Contact Lenses

Purpose

This research study is to see if using Lacrifill is safe, easy to use, and helpful for people who wear contact lenses but can't wear them comfortably for long. Specifically, the study aims to determine whether regular use of Lacrifill over a 2-3 month period can help people wear their contacts longer without discomfort and reduce signs and symptoms of dry eye.

Condition

  • Dry Eye

Eligibility

Eligible Ages
Over 22 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • >21 years of age - Contact lens wearer - Previous Dry Eye Treatment - Be on a stable dose of antihistamines/Birth Control Medication and Lifitegrast and cyclosporine. - Schrimers Anesthetized less than or equal to 10 - CLDEQ-8 greater than or equal to 12 - Corneal Staining NEI grading scale greater than or equal to 1

Exclusion Criteria

  • Known allergy to Hyaluronic Acid - Current topical ophthalmic drops other than dry eye treatment - Uncontrolled Diabetes - Diabetic Retinopathy - Pregnancy or Lactating - Corneal Surgery (except Refractive) - Corneal Scars - Keratoconus - Ocular Herpetic Keratitis

Study Design

Phase
Phase 4
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Lacrifill
  • Drug: Lacrifill
    Lacrifill is a cross-linked hyaluronic acid derivative that temporarily blocks tear drainage, allowing patients eyed to be bathed in their own natural tears.

Recruiting Locations

Eye Care Specialists
Kingston, Pennsylvania 18704
Contact:
Patti Myers
877-489-7405
patti.myers@vipeyes.com

More Details

Status
Recruiting
Sponsor
Vision Innovation Centers of Pennsylvania, LLC d/b/a Eye Care Specialists

Study Contact

Patti Myers, COT
5707145910
patti.myers@vipeyes.com